Stock LIPO LIPELLA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Lipella Pharmaceuticals Inc.

Equities

LIPO

US53630L1008

Market Closed - Nasdaq
Other stock markets
 01:30:00 22/06/2024 am IST 		5-day change 1st Jan Change
0.57 USD -11.49% Intraday chart for Lipella Pharmaceuticals Inc. -16.16% -44.12%
31/05 Lipella Pharmaceuticals Inc. Announces Completion of Site Initiation Visit for Phase 2A Trial of LP-310 in Oral Lichen Planus CI
09/05 Lipella Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Lipella Pharmaceuticals Inc.

Price target over the last 5 years

History of analyst recommendation changes

1baeafdd40c9387eb03d408.tjonSQhPyjKwaIBpcRc4Co61hn8Eq4qBQrclI_mZM-I.72NRHGwhvmCDKcgeQyJWPL3CxRJShtPrLJpuTr7oQq_nVn4wXAike4c62Q~1d696d2901564d2c7a1041c377d3b216

Analyst Recommendations on Lipella Pharmaceuticals Inc.

Maxim Initiates Lipella Pharmaceuticals at Buy Rating With $2 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.57 USD
Average target price
2 USD
Spread / Average Target
+250.88%
High Price Target
2 USD
Spread / Highest target
+250.88%
Low Price Target
2 USD
Spread / Lowest Target
+250.88%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Lipella Pharmaceuticals Inc.

Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LIPO Stock
  4. Consensus Lipella Pharmaceuticals Inc.